ArticleTherapeutic advances in medical oncology2026
Immune checkpoint inhibitor-based first-line therapies for advanced or unresectable hepatocellular carcinoma: a network meta-analysis and cost-effectiveness analysis.
Huijie Qi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.